Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms
Open Access
- 10 January 2013
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 121 (2), 260-269
- https://doi.org/10.1182/blood-2012-09-399725
Abstract
Precursor mRNA splicing is catalyzed by the spliceosome, a macromolecule composed of small nuclear RNAs associated with proteins. The SF3B1 gene encodes subunit 1 of the splicing factor 3b, which is important for anchoring the spliceosome to precursor mRNA. In 2011, whole-exome sequencing studies showed recurrent somatic mutations of SF3B1 and other genes of the RNA splicing machinery in patients with myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasm. SF3B1 mutations had a particularly high frequency among conditions characterized by ring sideroblasts, which is consistent with a causal relationship. SF3B1 mutants were also detected at a lower frequency in a variety of other tumor types. In chronic lymphocytic leukemia, SF3B1 was found to be the second most frequently mutated gene. In myelodysplastic syndromes, SF3B1 mutations appear to be founding genetic lesions and are associated with a low risk of leukemic evolution. In contrast, SF3B1 mutations have a lower incidence in early stages of chronic lymphocytic leukemia, are more common in advanced disease, and tend to be associated with poor prognosis, suggesting that they occur during clonal evolution of the disease. The assessment of SF3B1 mutation status may become innovative diagnostic and prognostic tools and the availability of spliceosome modulators opens novel therapeutic prospects.Keywords
This publication has 67 references indexed in Scilit:
- New connections between splicing and human diseaseTrends in Genetics, 2012
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2011
- Mutations in RNA Splicing Machinery in Human CancersThe New England Journal of Medicine, 2011
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsThe New England Journal of Medicine, 2011
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesThe New England Journal of Medicine, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene SplicingACS Chemical Biology, 2011
- The Spliceosome: Design Principles of a Dynamic RNP MachineCell, 2009
- The splicing factor SC35 has an active role in transcriptional elongationNature Structural & Molecular Biology, 2008
- Splicing in disease: disruption of the splicing code and the decoding machineryNature Reviews Genetics, 2007